Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1996-11-13
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0301-0430
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
419
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8793240-Aged,
pubmed-meshheading:8793240-Creatinine,
pubmed-meshheading:8793240-Cyclophosphamide,
pubmed-meshheading:8793240-Glomerulonephritis, Membranous,
pubmed-meshheading:8793240-Humans,
pubmed-meshheading:8793240-Immunosuppressive Agents,
pubmed-meshheading:8793240-Kidney Failure, Chronic,
pubmed-meshheading:8793240-Male,
pubmed-meshheading:8793240-Uremia
|
pubmed:year |
1996
|
pubmed:articleTitle |
Therapy of membranous nephropathy with severe azotemia.
|
pubmed:publicationType |
Letter,
Case Reports
|